Analyze Diet
European journal of human genetics : EJHG2025; doi: 10.1038/s41431-025-01845-6

An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression.

Abstract: Genome-wide association studies (GWAS) of disease progression are vulnerable to collider bias caused by selection of participants with disease at study entry. This bias introduces spurious associations between disease progression and genetic variants that are truly only associated with disease incidence. Methods of statistical adjustment to reduce this bias have been published, but rely on assumptions regarding the genetic correlation of disease incidence and disease progression which are likely to be violated in many human diseases. MR-Horse is a recently published Bayesian method to estimate the parameters of a general model of genetic pleiotropy in the setting of Mendelian Randomisation. We adapted this method to provide bias-reduced GWAS estimates of associations with disease progression, robust to the genetic correlation of disease incidence and disease progression and robust to the presence of pleiotropic variants with effects on both incidence and progression. We applied this adapted method to simulated GWAS of disease incidence and progression with pleiotropic variants and varying degrees of genetic correlation. When significant genetic correlation was present, the MR-Horse method produced less biased estimates than unadjusted analyses or analyses adjusted using other existing methods. Type 1 error rates with the MR-Horse method were consistently below the nominal 5% level, at the expense of a modest reduction in power. We then applied this method to summary statistics from the CKDGen consortium GWAS of kidney function decline. MR-Horse attenuated the effects of variants with known likely biased effects in the CKDGen GWAS, whilst preserving effects at loci with likely true effects.
Publication Date: 2025-06-03 PubMed ID: 40461637PubMed Central: 5556366DOI: 10.1038/s41431-025-01845-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents an adaptation of the MR-Horse method aimed at reducing selection bias in genome-wide disease progression studies. This improved procedure provides less biased estimates of disease progression, especially in cases where genetic correlation is significant.

Introduction to the Problem

  • In genome-wide association studies (GWAS) of disease progression, there is a known vulnerability to collider bias, which is a type of selection bias that occurs when subjects with the disease under study are specifically selected.
  • This bias leads to false associations between genetic variants and disease progression when these variants are only truly associated with disease incidence.
  • Previously, methods used to reduce this bias were based on assumptions regarding the genetic correlation of disease incidence and disease progression, however, these assumptions often do not hold true for numerous human diseases.

Introduction of the MR-Horse Method

  • The MR-Horse method is a Bayesian approach aimed at estimating the parameters of a general model of genetic pleiotropy (where a single gene impacts two or more traits independently) in Mendelian Randomisation settings.
  • Researchers adapted the MR-Horse method to offer GWAS estimates of associations with disease progression, which are robust against genetic correlation of disease incidence and disease progression.
  • This method is also robust in the presence of pleiotropic variants that have an impact on both disease incidence and progression.

Application of the MR-Horse Method and Results

  • The researchers applied the adapted MR-Horse method to simulated GWAS with pleiotropic variants and varying degrees of genetic correlation.
  • In situations where a significant genetic correlation existed, the MR-Horse method provided less biased estimates compared to analyses that were neither adjusted nor adjusted using other existing methods.
  • The MR-Horse method produced Type 1 error rates below the nominal 5%, although this was at the expense of a slight reduction in power.

Application to Real-World Data

  • The method was then applied to real-world data using summary statistics from the CKDGen consortium GWAS of kidney function decline.
  • The MR-Horse method was successful in reducing the effects of variants believed to have biased effects in the CKDGen GWAS while preserving the effects at locations with likely true effects.

Cite This Article

APA
Donovan K, Torres J, Zhu D, Herrington WG, Staplin N. (2025). An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression. Eur J Hum Genet. https://doi.org/10.1038/s41431-025-01845-6

Publication

ISSN: 1476-5438
NlmUniqueID: 9302235
Country: England
Language: English

Researcher Affiliations

Donovan, Killian
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK. killian.donovan@ndph.ox.ac.uk.
Torres, Jason
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
Zhu, Doreen
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
Herrington, William G
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
Staplin, Natalie
  • Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Grant Funding

  • TF_001_20220708 / Kidney Research UK

Conflict of Interest Statement

Competing interests: The authors declare no competing interests. Ethical approval: No ethical approval was required for this work as we used only simulated data or publicly available summary statistics.

References

This article includes 23 references
  1. Galesloot TE, Grotenhuis AJ, Kolev D, Aben KK, Bryan RT, Catto JWF. Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non-muscle-invasive bladder cancer.. Eur Urol Oncol 2022;5:70–83.
    doi: 10.1016/j.euo.2021.07.001pubmed: 34353775google scholar: lookup
  2. Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP. Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis.. JAMA Neurol 2016;73:812–20.
    doi: 10.1001/jamaneurol.2016.1114pubmed: 27244217pmc: 5556366google scholar: lookup
  3. Chang I-S, Jiang SS, Yang JC-H, Su W-C, Chien L-H, Hsiao C-F. Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors.. Am J Respir Crit Care Med 2017;195:663–73.
    doi: 10.1164/rccm.201602-0300OCpubmed: 27669169pmc: 5363976google scholar: lookup
  4. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias.. Epidemiology 2004;15:615.
  5. Dahabreh IJ, Kent DM. Index event bias: an explanation for the paradoxes of recurrence risk research.. JAMA: J Am Med Assoc 2011;305:822–3.
    doi: 10.1001/jama.2011.163google scholar: lookup
  6. Mitchell RE, Hartley AE, Walker VM, Gkatzionis A, Yarmolinsky J, Bell JA. Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression.. PLoS Genet 2023;19:e1010596.
    doi: 10.1371/journal.pgen.1010596pubmed: 36821633pmc: 9949638google scholar: lookup
  7. Dudbridge F, Allen RJ, Sheehan NA, Schmidt AF, Lee JC, Jenkins RG. Adjustment for index event bias in genome-wide association studies of subsequent events.. Nat Commun 2019;10:1561.
    doi: 10.1038/s41467-019-09381-wpubmed: 30952951pmc: 6450903google scholar: lookup
  8. Cai S, Hartley A, Mahmoud O, Tilling K, Dudbridge F. Adjusting for collider bias in genetic association studies using instrumental variable methods.. Genet Epidemiol 2022;46:303–16.
    doi: 10.1002/gepi.22455pubmed: 35583096pmc: 9544531google scholar: lookup
  9. Robinson-Cohen C, Triozzi JL, Rowan B, He J, Chen HC, Zheng NS. Genome-wide association study of CKD progression.. J Am Soc Nephrology: JASN 2023;34:1547–59.
  10. Mahmoud O, Dudbridge F, Davey Smith G, Munafo M, Tilling K. A robust method for collider bias correction in conditional genome-wide association studies.. Nat Commun 2022;13:619.
    doi: 10.1038/s41467-022-28119-9pubmed: 35110547pmc: 8810923google scholar: lookup
  11. Grant AJ, Burgess S. A Bayesian approach to Mendelian randomization using summary statistics in the univariable and multivariable settings with correlated pleiotropy.. Am J Hum Genet 2024;111:165–80.
    doi: 10.1016/j.ajhg.2023.12.002pubmed: 38181732pmc: 10806746google scholar: lookup
  12. Carvalho CM, Polson NG, Scott JG. The horseshoe estimator for sparse signals.. Biometrika 2010;97:465–80.
    doi: 10.1093/biomet/asq017google scholar: lookup
  13. Gorski M, Rasheed H, Teumer A, Thomas LF, Graham SE, Sveinbjornsson G. Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies.. Kidney Int 2022;102:624–39.
    doi: 10.1016/j.kint.2022.05.021pubmed: 35716955pmc: 10034922google scholar: lookup
  14. Hardy GH. Mendelian proportions in a mixed population.. Sci (N Y, NY) 1908;28:49–50.
    doi: 10.1126/science.28.706.49google scholar: lookup
  15. Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M. A catalog of genetic loci associated with kidney function from analyses of a million individuals.. Nat Genet 2019;51:957–72.
    doi: 10.1038/s41588-019-0407-xpubmed: 31152163pmc: 6698888google scholar: lookup
  16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D. PLINK: a tool set for whole-genome association and population-based linkage analyses.. Am J Hum Genet 2007;81:559–75.
    doi: 10.1086/519795pubmed: 17701901pmc: 1950838google scholar: lookup
  17. Gorski M, Jung B, Li Y, Matias-Garcia PR, Wuttke M, Coassin S. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline.. Kidney Int 2021;99:926–39.
    doi: 10.1016/j.kint.2020.09.030pubmed: 33137338google scholar: lookup
  18. Zeng J, de Vlaming R, Wu Y, Robinson MR, Lloyd-Jones LR, Yengo L. Signatures of negative selection in the genetic architecture of human complex traits.. Nat Genet 2018;50:746–53.
    doi: 10.1038/s41588-018-0101-4pubmed: 29662166google scholar: lookup
  19. Zhu Z, Bakshi A, Vinkhuyzen Anna AE, Hemani G, Lee S, Nolte Ilja M. Dominance genetic variation contributes little to the missing heritability for human complex traits.. Am J Hum Genet 2015;96:377–85.
    doi: 10.1016/j.ajhg.2015.01.001pubmed: 25683123pmc: 4375616google scholar: lookup
  20. Piironen J, Vehtari A. On the hyperprior choice for the global shrinkage parameter in the horseshoe prior.. Artif. Intell. Stat. 2017;905–13.
  21. Chathrath A, Ratan A, Dutta A. Germline variants that affect tumor progression.. Trends Genet 2021;37:433–43.
    doi: 10.1016/j.tig.2020.10.005google scholar: lookup
  22. Burgess S, Small D, Thompson S. A review of instrumental variable estimators for Mendelian Randomization.. Stat Methods Med Res 2015;26:2333–55.
  23. Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success.. Nature 2024;629:624–9.
    doi: 10.1038/s41586-024-07316-0pubmed: 38632401pmc: 11096124google scholar: lookup

Citations

This article has been cited 0 times.